drugset / Trial / NCT02973958

Evaluating Pain Outcomes of Ketorolac Administration in Children Undergoing Circumcision

NCT02973958

Phase 1 Completed 30 enrolled Alberta Children's Hospital
RandomizedParallel-groupSingle-blindSupportive care

Summary

Circumcision is the most common surgical procedure performed by Pediatric Urologists. Ketorolac has been shown to have an efficacy similar to morphine in multi-modal analgesic regimens without the commonly associated adverse effects. This study aims to see if giving ketorolac during the operation will result in better pain control. We hypothesize that ketorolac will result in pain control similar to morphine with a lower incidence of side effects such as nausea and vomiting.

Timeline

Start
2017-02-01
Primary completion
2018-06-28
Completion
2018-06-28

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketorolac Other / unclassified 0.5 mg/kg Intravenous
Background Acetaminophen Small molecule 15 mg/kg Oral
Background Bupivacaine Other / unclassified 0.2 unknown Other
Background Ibuprofen Small molecule
Background Sevoflurane Other / unclassified 1 unknown Inhaled